Prediction of Clinical Outcome in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy by Plasma Markers

PURPOSE: To identify cytokines in plasma that may predict objective response and progression-free survival (PFS) in patients with locally advanced non-small cell lung cancer (NSCLC) treated with chemoradiotherapy. MATERIALS AND METHODS: From April 2016 to May 2017, thirty-one patients with locally a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, Xin, Jiang, Leilei, Teng, Huajing, Mi, Lan, Li, Bo, Shi, Anhui, Yu, Rong, Li, Dongming, Dong, Xin, Yang, Dan, Yu, Huiming, Wang, Weihu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925829/
https://www.ncbi.nlm.nih.gov/pubmed/33680949
http://dx.doi.org/10.3389/fonc.2020.625911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925829/
https://www.ncbi.nlm.nih.gov/pubmed/33680949
http://dx.doi.org/10.3389/fonc.2020.625911

Ejemplares similares